Health


Recent Health Stories

A Cleveland Clinic study of nearly 8,000 patients finds that stopping semaglutide or tirzepatide leads to far less weight regain than clinical trials suggested.
Most patients who stopped Ozempic or Mounjaro pursued alternative treatments, limiting weight regain far below what clinical trials predicted, a new study finds.
Mac Oliveauupda